Keywords: EPHA, Transparency, European drug pricing, Reimbursement

EPHA calls for transparency of European medicines pricing

Article | 07 June 2011

In the framework of the European Commission consultation of the possible revision of the directive on the transparency of measures ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in